Breathe Well Live Well
|
Vectura Path Clearer In US As VR315 EU Launch Nears
Wall Street Journal LN) asthma blockbuster Advair. Novartis AG's (NOVN.VX) generics unit Sandoz relinquished the US rights to VR315 in March amid uncertainty about the … |
View full post on asthma – Google News
 Stockopedia |
CORRECT: Vectura Licenses Patents To GlaxoSmithKline
Wall Street Journal VX) generics unit Sandoz handed back the US rights to VR315, a generic version of an asthma drug, to Vectura. Analysts said it signaled Sandoz wasn't sure … INTERVIEW: Vectura Patents For GSK's 573719 And 642444 Vectura and GlaxoSmithKline sign agreement over asthma patents Vectura boosted by deal with GSK worth over $30 million upfront plus royalties … |
View full post on asthma – Google News